Zobrazeno 1 - 10
of 65
pro vyhledávání: '"MAXIMILIAN MAECHLER"'
Autor:
Christoph H. Saely, Maximilian Maechler, Alexander Vonbank, Lukas Sprenger, Arthur Mader, Barbara Larcher, Daniela Zanolin-Purin, Andreas Leiherer, Axel Muendlein, Heinz Drexel
Publikováno v:
Data in Brief, Vol 40, Iss , Pp 107817- (2022)
We investigated 180 consecutive patients with congestive heart failure (CHF), of whom 83 had type 2 diabetes (T2DM) and 97 did not have diabetes as well as 223 controls without CHF, of whom 39 had T2DM and 184 did not have diabetes. Data was recorded
Externí odkaz:
https://doaj.org/article/767737c3831e478395f71cc4d33efb56
Autor:
ARTHUR MADER, CHRISTOPH H. SAELY, MAXIMILIAN MAECHLER, BARBARA LARCHER, LUKAS SPRENGER, ANDREAS LEIHERER, AXEL MUENDLEIN, ALEXANDER VONBANK, HEINZ DREXEL
Publikováno v:
Diabetes. 71
Cystatin C is an established biomarker for renal function, and, given the close association of chronic kidney disease and cardiovascular disease might indicate new-onset or deteriorating cardiovascular disease. However, evidence for cystatin C as a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22e6c8d84b4493821c5c4f589fa14e08
https://doi.org/10.2337/db22-420-p
https://doi.org/10.2337/db22-420-p
Autor:
LUKAS SPRENGER, MAXIMILIAN MAECHLER, ALEXANDER VONBANK, BARBARA LARCHER, ARTHUR MADER, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Publikováno v:
Diabetes. 71
Non-Alcoholic Fatty Liver Disease (NAFLD) is associated with insulin resistance, type 2 diabetes (T2DM) and cardiovascular disease. However, data on NAFLD in patients with established cardiovascular disease (CVD) are scarce. Here, we therefore aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::278772136e3bd0512091e2b19f9edc22
https://doi.org/10.2337/db22-427-p
https://doi.org/10.2337/db22-427-p
Autor:
ANDREAS LEIHERER, AXEL MUENDLEIN, EVA MARIA BRANDTNER, CHRISTOPH H. SAELY, ALEXANDER VONBANK, ARTHUR MADER, LUKAS SPRENGER, MAXIMILIAN MAECHLER, BARBARA LARCHER, ANTTI JYLHA, MITJA LAAPERI, REIJO LAAKSONEN, WINFRIED MAERZ, PETER FRAUNBERGER, MARCUS KLEBER, HEINZ DREXEL
Publikováno v:
Diabetes. 71
Serum lipids and metabolic diseases, in particular type 2 diabetes (T2D) and nonalcoholic fatty liver disease (NAFLD) , predict the atherosclerotic diseases coronary artery disease (CAD) and peripheral arterial disease (PAD) . However, it is not know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2facfe0fc83d20be6b26dde35421d820
https://doi.org/10.2337/db22-209-or
https://doi.org/10.2337/db22-209-or
Autor:
ARTHUR MADER, LUKAS SPRENGER, ALEXANDER VONBANK, BARBARA LARCHER, MAXIMILIAN MAECHLER, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Publikováno v:
Diabetes. 71
Remnant cholesterol, which is calculated as total cholesterol minus LDL cholesterol minus HDL cholesterol has attracted interest as a marker of cardiovascular event risk. The power of remnant cholesterol to predict major cardiovascular events (MACE)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f1c25e62a6c7f65385e43c024f20b33
https://doi.org/10.2337/db22-430-p
https://doi.org/10.2337/db22-430-p
Autor:
LUKAS SPRENGER, MAXIMILIAN MAECHLER, ALEXANDER VONBANK, BARBARA LARCHER, ARTHUR MADER, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Publikováno v:
Diabetes. 71
Type 2 diabetes (T2DM) and chronic kidney disease (CKD) both confer a high risk of cardiovascular disease (CVD) , and these conditions frequently coincide. The aim of this study was to investigate the single and joint effects of T2DM and CKD on major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71d63a086c3f8d450d98ff04b30d0f4d
https://doi.org/10.2337/db22-326-or
https://doi.org/10.2337/db22-326-or
Autor:
LUKAS SPRENGER, MAXIMILIAN MAECHLER, ALEXANDER VONBANK, BARBARA LARCHER, ARTHUR MADER, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Publikováno v:
Diabetes. 71
Chronic kidney disease (CKD) is a paramount indicator of cardiovascular risk and is highly prevalent in patients with established cardiovascular disease, especially among those with type 2 diabetes (T2DM) . Peripheral artery disease (PAD) confers an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b46c015bd73c2191984a02b80650ed07
https://doi.org/10.2337/db22-419-p
https://doi.org/10.2337/db22-419-p
Autor:
MAXIMILIAN MAECHLER, LUKAS SPRENGER, ARTHUR MADER, BARBARA LARCHER, ALEXANDER VONBANK, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Publikováno v:
Diabetes. 71
A low LDL-C / apoB ratio reflects small LDL particle size and is associated with insulin resistance. Nonalcoholic fatty liver disease (NALFD) is an important feature of the insulin resistance syndrome and confers an increased cardiovascular risk. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ceab1747b89dd7887d0661f6df9bf76
https://doi.org/10.2337/db22-1096-p
https://doi.org/10.2337/db22-1096-p
Autor:
MAXIMILIAN MAECHLER, LUKAS SPRENGER, ARTHUR MADER, BARBARA LARCHER, ALEXANDER VONBANK, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Publikováno v:
Diabetes. 71
Elevated pro-B type natriuretic peptide (pro-BNP) has been found to be a strong marker of cardiovascular risk in several high-risk populations. However, the power of pro-B type natriuretic peptide (pro-BNP) to predict major cardiovascular events (MAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::235302b400bca2c40b296829f1e3ffdb
https://doi.org/10.2337/db22-429-p
https://doi.org/10.2337/db22-429-p
Autor:
LUKAS SPRENGER, MAXIMILIAN MAECHLER, ALEXANDER VONBANK, BARBARA LARCHER, ARTHUR MADER, ANDREAS LEIHERER, AXEL MUENDLEIN, HEINZ DREXEL, CHRISTOPH H. SAELY
Publikováno v:
Diabetes. 71
The A Body Shape index (ABSI) is a validated measure of visceral adiposity that is calculated based on waist circumference, height and BMI. Its power to predict major cardiovascular events in patients with established cardiovascular disease (CVD) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::165178edcaf0196f744f28a38be79b9a
https://doi.org/10.2337/db22-433-p
https://doi.org/10.2337/db22-433-p